NIAID Banner Logo Image


1. 48432 HIV-LS-341; PUBMED-HIV-2/6/2006

Probabilistic Neural Network Model for the In Silico Evaluation of Anti-HIV Activity and Mechanism of Action

Vilar, S, Santana, L, and Uriarte, E

J Med Chem 2006. 49(3): 1118-24


2. 48433 HIV-LS-341; PUBMED-HIV-2/6/2006

Structure-Based Design, Synthesis, and Biological Evaluation of Novel Inhibitors of Human Cyclophilin A

Guichou, JF, Viaud, J, Mettling, C, Subra, G, Lin, YL, and Chavanieu, A

J Med Chem 2006. 49(3): 900-910


3. 48434 HIV-LS-341; PUBMED-HIV-2/6/2006

CD4-Specific Transgenic Expression of Human Cyclin T1 Markedly Increases Human Immunodeficiency Virus Type 1 (HIV-1) Production by CD4+ T Lymphocytes and Myeloid Cells in Mice Transgenic for a Provirus Encoding a Monocyte-Tropic HIV-1 Isolate

Sun, J, Soos, T, Kewalramani, VN, Osiecki, K, Zheng, JH, Falkin, L, Santambrogio, L, Littman, DR, and Goldstein, H

J Virol 2006. 80(4): 1850-62


4. 48435 HIV-LS-341; SCIFINDER-HIV-1/31/2006

Kalata B8, a novel antiviral circular protein, exhibits conformational flexibility in the cystine knot motif

Daly, Norelle L, Clark, Richard J, Plan, Manuel R, and Craik, David J

Biochemical Journal 2006. 393(3): 619-626

5. 48436 HIV-LS-341; SCIFINDER-HIV-1/31/2006

Quinoline derivatives and other compounds, pharmaceutical compositions, and methods for inhibiting HIV infectivity

Li, Limin

PATENT: WO 2006004608 ISSUE DATE: 20060112

APPLICATION: 2005 PP: 30 pp.

ASSIGNEE: (Functional Genetics, Inc. USA

6. 48437 HIV-LS-341; SCIFINDER-HIV-1/31/2006

Uracil DNA glycosylase is dispensable for human immunodeficiency virus type 1 replication and does not contribute to the antiviral effects of the cytidine deaminase Apobec3G

Kaiser, Shari M and Emerman, Michael

Journal of Virology 2006. 80(2): 875-882

7. 48438 HIV-LS-341; PUBMED-HIV-2/6/2006

Synthesis and anti-HIV activity of beta-D-3'-azido-2',3'-unsaturated nucleosides and beta-D-3'-azido-3'-deoxyribofuranosylnucleosides

Gadthula, S, Chu, CK, and Schinazi, RF

Nucleosides Nucleotides Nucleic Acids 2005. 24(10-12): 1707-27


8. 48439 HIV-LS-341; SCIFINDER-HIV-1/31/2006

Anti-retroviral moronic acid derivatives

Lee, Kuo-Hsiung, Chang, Fang-Rong, Sakurai, Yojiro, and Chen, Chin Ho

PATENT: WO 2006001964 ISSUE DATE: 20060105

APPLICATION: 2005 PP: 23 pp.

ASSIGNEE: (The University of North Carolina At Chapel Hill, USA

9. 48440 HIV-LS-341; SCIFINDER-HIV-1/31/2006

Compounds for immunopotentiation

Valiante, Nicholas and Xu, Feng

PATENT: WO 2006002422 ISSUE DATE: 20060105

APPLICATION: 2005 PP: 178 pp.

ASSIGNEE: (Chiron Corporation, USA

10. 48441 HIV-LS-341; PUBMED-HIV-2/6/2006

In Vitro Antiretroviral Activity and In Vitro Toxicity Profile of SPD754, a New Deoxycytidine Nucleoside Reverse Transcriptase Inhibitor for Treatment of Human Immunodeficiency Virus Infection

Gu, Z, Allard, B, de, Muys JM, Lippens, J, Rando, RF, Nguyen-Ba, N, Ren, C, McKenna, P, Taylor, DL, and Bethell, RC

Antimicrob Agents Chemother 2006. 50(2): 625-31


11. 48442 HIV-LS-341; SCIFINDER-HIV-1/31/2006

Methods and compositions for enhancement of immunity by in vivo depletion of immunosuppressive cell activity

Vieweg, Johannes W

PATENT: US 2006002932 ISSUE DATE: 20060105

APPLICATION: 2005-13011 PP: 40 pp.

ASSIGNEE: (Duke University, USA

12. 48443 HIV-LS-341; SCIFINDER-HIV-1/31/2006

Sigma-2 receptor agonists and their use in the treatment of HIV or other immunodeficiency virus infection

Bowen, Wayne D, Crawford, Keith W, and Hildreth, James E

PATENT: US 2006004036 ISSUE DATE: 20060105

APPLICATION: 2005-50725 PP: 27 pp., Cont.-in-part of Appl. No. PCT/US04-000739.

ASSIGNEE: (The United States of America, Per Secy. Dhhs Nih USA

13. 48444 HIV-LS-341; SCIFINDER-HIV-1/31/2006

An inhibitor of c-Jun N-terminal kinases (CEP-11004) counteracts the anti-HIV-1 action of trichosanthin

Ouyang, Dong-Yun, Chan, Herman, Wang, Yuan-Yuan, Huang, Hai, Tam, Siu-Cheung, and Zheng, Yong-Tang

Biochemical and Biophysical Research Communications 2006. 339(1): 25-29

14. 48445 HIV-LS-341; WOS-HIV-1/29/2006

Identification of peptides from human pathogens able to cross-activate an HIV-1-gag-specific CD4(+) T cell clone

Venturini, S, Allicotti, G, Zhao, YD, Simon, R, Burton, DR, Pinilla, C, and Poignard, P



15. 48446 HIV-LS-341; WOS-HIV-1/29/2006

Efficient intervention of growth and infiltration of primary adult T-cell leukemia cells by an HIV protease inhibitor, ritonavir

Dewan, MZ, Uchihara, J, Terashima, K, Honda, M, Sata, T, Ito, M, Fujii, N, Uozumi, K, Tsukasaki, K, Tomonaga, M, Kubuki, Y, Okayama, A, Toi, M, Mori, N, and Yamamoto, N

BLOOD 2006. 107(2): 716-724, 9


16. 48447 HIV-LS-341; WOS-HIV-1/29/2006

Smilaxin, a novel protein with immunostimulatory, antiproliferative, and HIV-1-reverse transcriptase inhibitory activities from fresh Smilax glabra rhizomes

Chu, KT and Ng, TB



17. 48448 HIV-LS-341; WOS-HIV-1/29/2006

Hypertriglyceridemia and hypercholesterolemia in human immunodeficiency virus-1-infected children treated with protease inhibitors

Santos, FS, Rangel, LGG, Saucedo, GP, Rosales, GV, and Novales, MGM

ARCHIVES OF MEDICAL RESEARCH 2006. 37(1): 129-132, 4


18. 48449 HIV-LS-341; WOS-HIV-1/29/2006

Inhibition of drug-resistant HIV-1 by RNA interference

Huelsmann, PM, Rauch, P, Allers, K, John, MJ, and Metzner, KJ

ANTIVIRAL RESEARCH 2006. 69(1): 1-8, 8


19. 48450 HIV-LS-341; WOS-HIV-2/5/2006

Synthesis of tetrahydrobenzazepinesulfonamides and their rearrangement to diarylsulfones

Ren, H, Zanger, M, and McKee, JR

SYNTHETIC COMMUNICATIONS 2006. 36(3): 355-363, 9


20. 48451 HIV-LS-341; WOS-HIV-2/5/2006

APOBEC3A and APOBEC3B are potent inhibitors of LTR-retrotransposon function in human cells

Bogerd, HP, Wiegand, HL, Doehle, BP, Lueders, KK, and Cullen, BR

NUCLEIC ACIDS RESEARCH 2006. 34(1): 89-95, 7


21. 48452 HIV-LS-341; WOS-HIV-2/5/2006

A model predictive control based scheduling method for HIV therapy

Zurakowski, R and Teel, AR

JOURNAL OF THEORETICAL BIOLOGY 2006. 238(2): 368-382, 15


22. 48453 HIV-LS-341; WOS-HIV-2/5/2006

Variations in plasmacytoid dendritic cell (PDC) and myeloid dendritic cell (MDC) levels in HIV-infected subjects on and off antiretroviral therapy

Schmidt, B, Fujimura, SH, Martin, JN, and Levy, JA



23. 48454 HIV-LS-341; WOS-HIV-2/5/2006

HIV-1 protease inhibitors and cytomegalovirus vMIA induce mitochondrial fragmentation without triggering apoptosis

Roumier, T, Szabadkai, G, Simoni, AM, Perfettini, JL, Paulau, AL, Castedo, M, Metivier, D, Badley, A, Rizzuto, R, and Kroemer, G

CELL DEATH AND DIFFERENTIATION 2006. 13(2): 348-351, 4


If using ChemDB information for publication or abstract presentation, please cite the website in addition to the original information source.    Database last updated: September 2023